Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 25, 1991 - Issue 2
Submit an article Journal homepage
7
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Bacillus Calmette-GuÉrin Treatment of 39 Patients with Superficial Transitional Cell Carcinoma of the Bladder

Maaz Al Amin Al Khalifa Department of Urology, University Hospital, Lund, Sweden
,
P. Elfving Department of Urology, University Hospital, Lund, Sweden
,
W. Månsson Department of Urology, University Hospital, Lund, Sweden
&
S. Colleen Department of Urology, University Hospital, Lund, Sweden
Pages 135-139 | Received 15 Jun 1990, Accepted 20 Aug 1990, Published online: 09 Jul 2009

References

  • Herr H W, Pinsky C M, Whitmore W F, Jr, Sogani P C, Oettgen H F, Melamed M R. Long term effect of infra-vesical BCG on flat carcinoma in situ of the bladder. J Urol 1986; 135: 265–267
  • Horn Y, Eidelman A, Walach N, Ilian M. Intravesical chemotherapy in a controlled trial with Thio-Tepa versus doxorubicin hydrochloride. J Urol 1981; 125: 652–654
  • Kaisary A V. Intravesical BCG-therapy in the management of multiple superficial bladder carcinoma. Comparison between Glaxo and Pasteur strains. Br J Urol 1987; 59: 554–558
  • Kelly D R, Haaff E O, Becich M, Lage J, Bauer W C, Dresner S M, Catalona W J, Ratliff T L. Prognostic value of purified protein derivative skin-test and granuloma formation in patients treated with intravesical Bacillus Calmette-Guérin. J Urol 1986; 135: 268–271
  • Koontz W N, Prout G R, Smith W, Jr, Frable W J, Minnis J E. The use of intravesical Thio-Tepa in the management of non-invasive carcinoma of the bladder. J Urol 1981; 125: 307–312
  • Lamm D L. Bacillus Calmette-Guérin immunotherapy for bladder cancer. J Urol 1985; 134: 40–47
  • Lamm D L, Stogdill V D, Stogdill B J, Crispen R G. Complications of Bacillus Calmette-Guérin immunotherapy in 1278 patients with bladder cancer. J Urol 1986; 135: 272–274
  • Lamm D L, Thor D E, Winters W D, Stogdill V D, Radwin H M. BCG immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses. Cancer 1981; 48: 82–88
  • van Der Meijden A P M. Non-specific immunotherapy with BCG-RIVM in superficial bladder cancer. Histo-logical, immunological and therapeutic aspects. Wibro Dissertatiedrukkerij, HelmondNetherlands, ISBN 90 900 2361 5
  • Morales A, Nickel J G. Immunotherapy of superficial bladder cancer with BCG. World J Urol 1986; 3: 209–214
  • Rawls W H, Lamm D L, Eyolfson M F. Septic complications in the use of Bacillus Calmette-Guérin for non-invasive transitional cell carcinoma. J Urol 1988; 139: 300A
  • Riddle P R. The management of superficial bladder tumors with intravesical Epodyl. Br J Urol 1973; 45: 84–87
  • Solowsky M S, Murphy W M, DeFuria M D, Crooke S, Finebaurn P. The effect of mitomycin C on superficial bladder cancer. J Urol 1981; 125: 646–648

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.